North America Sickle Cell Disease Market Detailed Segmentation:
By Disease Type (Revenue, USD Mn, 2021 - 2033)
- Sickle Cell Anemia
- Sickle Beta Thalassemia
- Sickle Hemoglobin C Disease
By Drug Type (Revenue, USD Mn, 2021 - 2033)
- Hydroxyurea
- L-glutamine
- Crizanlizumab
- Pain-relievers
- Voxelotor
- Others
By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Country (Revenue, USD Mn, 2021 - 2033)
- U.S.
- Canada